EU to decide on Zimmer's $13.4 bln Biomet deal by July 9
BRUSSELS, June 4
BRUSSELS, June 4 (Reuters) - European Union antitrust regulators will decide by July 9 whether to clear U.S. orthopedic products maker Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc, one of several recent takeovers in the pharmaceutical industry.
The deal will push Zimmer up to the No. 2 spot behind Johnson & Johnson.
Zimmer sought EU clearance on June 3, the European Commission's website showed on Wednesday. The EU competition watchdog can either clear the deal, demand concessions or open a lengthy investigation if there are regulatory concerns.
Zimmer expects to close the deal in the first quarter of 2015. (Reporting by Foo Yun Chee; Editing by Erica Billingham)
- Maine nurse fights Ebola quarantine, says will not be bullied |
- Dollar surges as Fed ends QE on hawkish note
- SoftBank's humanoid robot lands job as Nescafe salesman
- Ukraine gas supplies in doubt as Russia seeks EU payment deal
- Clashes erupt as Israeli police kill Palestinian suspected of shooting Jewish far-rightist